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While uncontrolled diabetes (UD) or poor glycaemic control is a widespread condition with 
potentially life-threatening consequences, there is sparse evidence of its effects on health care 
utilisation. We jointly model the propensities to consume health care and UD by employing an 
innovative bivariate Latent Markov model which allows for dynamic unobserved 
heterogeneity, movements between latent states and the endogeneity of UD. We estimate the 
effects of UD on primary and secondary health care consumption using a panel dataset of rich 
administrative records from Spain and measure UD using a biomarker. We find that, 
conditional on time-varying unobservables, UD does not have a statistically significant direct 
effect on health care use. Furthermore, individuals appear to move across latent classes and 
increase their propensities to poor glycaemic control and health care use over time. Our results 
suggest that by ignoring time-varying unobserved heterogeneity and the endogeneity of UD, 
the effects of UD on health care utilisation might be overestimated and this could lead to biased 
findings. Our approach reveals heterogeneity in behaviour beyond standard groupings of 
frequent versus infrequent users of health care services. We argue that this dynamic latent 
Markov approach could be used more widely to model the determinants of health care use. 
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Diabetes mellitus (DM) is a major public health concern and one of the most widespread 
chronic conditions worldwide with a rapidly increasing prevalence, especially among low- and 
middle-income countries (IDF, 2015). According to the WHO (2016), we are currently 
experiencing a diabetes “epidemic” where the number of adults with DM has grown from 108 
million in 1980 to an estimated 422 million in 2014 and with DM projected to be the 7th leading 
cause of death by 2030. Furthermore, DM imposes a substantial economic burden to any health 
care system. Among individuals with DM, uncontrolled diabetes (UD) or poor glycaemic 
control is a prevalent condition, concerning between around 30 to 50 percent of patients. 
Glycaemic control is driven by a variety of factors such as genetic endowment; lifestyle; 
resistance to intensified medication (therapeutic resistance); and low treatment adherence. UD 
leads to sustained higher levels of blood sugar, which in turn increase the risk of life-threatening 
comorbidities such as kidney failure and stroke.   
A related problem is the extent to which UD may cause additional, yet avoidable, health care 
utilisation. Indeed, the medical literature often finds that individuals with poor glycaemic 
control tend to use more health care resources resulting in extra utilisation and added costs for 
the health system (e.g. Wagner et al., 2001; Gilmer et al., 2005; Mata-Cases et al., 2016). 
However, the majority of these studies employ empirical approaches often based on standard 
(linear) regression models applied to selected samples of US health insurance enrolees. Such 
samples tend to limit the generalisability of the results while previous empirical approaches do 
not account for potentially important issues which may affect the identification of the effect of 
DM on health care use such as individual-level unobserved heterogeneity and endogeneity 
concerns.  
The main objective of this paper is to jointly model the propensities towards poor glycaemic 
control and the use health care services via a bivariate Latent Markov (LM) model. This novel 
approach builds on some recent developments within the literature concerning latent class 
models (see Bartolucci et al., 2013 and 2014, for a comprehensive overview) and allows 
accounting for the endogeneity of UD and time-varying unobserved heterogeneity using 
dynamic latent classes. We apply this model to the relationship between UD and utilisation of 
primary and secondary health care services among individuals with type-2 diabetes. We 
employ six waves (2005-2010) of a longitudinal administrative dataset from Spain including 
detailed medical records of adult individuals with diabetes. We measure UD using glycated 
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haemoglobin (HbA1c) levels, a biomarker providing an accurate average measurement of 
glucose (sugar) concentration which is commonly used by physicians to diagnose and monitor 
diabetes and its severity (e.g. International Expert Committee, 2009; Lyons and Basu, 2012). 
Differently from previous studies, we find that conditional on the dynamic latent process poor 
glycaemic control does not appear to increase health care use among individuals with diabetes. 
We also find that the association between UD and health care utilisation tend to disappear when 
controlling for unobserved heterogeneity. This may suggest that UD and health care 
consumption might be both driven by a series of unobserved factors. Furthermore, our bivariate 
LM model reveals the existence of a series of (latent) groups of individuals, which differ by 
their propensities towards poor glycaemic control and health care use. Interestingly, patients 
who present a high propensity to consume health care do not necessarily show a similar 
tendency to poor glycaemic control. Our estimates also indicate that individuals may switch 
groups over time often by increasing their propensities to poor glycaemic control and utilisation 
of primary and secondary care. This also suggests that unobserved heterogeneity is, in this case, 
time-varying and that ignoring this would lead to biased estimates and misleading policy 
implications.       
This paper offers several contributions to the literature. First, to the best of our knowledge, this 
is one of the first studies to employ a bivariate LM model with dynamic unobserved 
heterogeneity to explore the determinants of health care utilisation and the first to model the 
propensities to consume health care and poor glycaemic control simultaneously. Secondly, our 
latent class model allows switching latent class over time, thus enabling changes in behaviour 
among individuals with diabetes while also accounting for important underlying causes of 
utilisation such as the ageing process. Finally, this is also the only paper employing a latent 
class model to investigate the relationship between UD and health care utilisation. Overall, this 
paper provides new evidence to the literature on (uncontrolled) diabetes and health care use 
while also proposing a novel dynamic latent class approach.  
2. Background 
Previous analyses within the medical literature consistently find that poor glycaemic control is 
associated with higher health care utilisation and increased medical costs (e.g. Wagner et al., 
2001; Shetty et al., 2005; Oglesby et al., 2006). For instance, Wagner et al. (2001) employ 
linear and log-linear models on US health insurance claims data of adult patients with diabetes 
collected between 1992-1997 to analyse the relationship between uncontrolled diabetes, health 
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care use and related costs. They find that sustained reductions of blood sugar levels are 
correlated with lower utilisation, including hospitals’ admission rates, primary and specialist 
visits, and significant costs savings. Similarly, Shetty et al. (2005) and Oglesby et al. (2006) 
use Generalised Linear Models (GLM) on data concerning patients with type-2 DM drawn 
from the US Health Core Managed Care Database (1998-2003). Overall, they find that, 
depending on their specific treatment between 41 to 66 percent of patients present a 
“suboptimal” control of their conditions and that the direct medical costs of treating patients 
with diabetes are higher among those with suboptimal glycaemic control. 
However, most of these studies are based on standard regression models such as linear, log-
linear and Generalised Linear Models (GLM; McCullagh and Nelder, 1989) applied to specific 
samples of US health insurance enrolees. These approaches tend to ignore potentially important 
modelling issues such as individual-level unobserved heterogeneity and the endogeneity of 
UD. Furthermore, with the exception of Gil et al. (2017), the economic literature has 
traditionally focused on the effects of DM on the labour market, including earnings, hours of 
work and absenteeism (Rizzo et al., 1996; Kahn, 1998; Latif, 2009; Zhang et al., 2009; Minor, 
2010) while overlooking the impact of DM or UD on health care use.  
The analysis of the determinants of health care utilisation has received considerable attention 
within the empirical economics literature. Early studies employ hurdle (e.g. Pohlmeier and 
Ulrich, 1995; Santos-Silva and Windmeijer, 2001; Schellhorn et al., 2000; Jimenez-Martin et 
al., 2002; Van Ourti, 2004) and finite mixture models (e.g. Deb and Trivedi, 1997; Deb and 
Holmes, 2000; Deb and Trivedi, 2002; Jimenez-Martin et al., 2002; Atella et al., 2004) to 
explore the factors influencing health care use mainly on cross-sectional data. More recent 
papers exploit panel data and propose latent class models which account for individual-level 
unobserved heterogeneity (e.g. Bago d’Uva, 2005) as well combinations of hurdle and latent 
class models (e.g. Bago d’Uva, 2006; Bago d’Uva and Jones, 2009).  
Latent class models present a series of attractive modelling features. First, the use of latent 
classes allows modelling unobserved heterogeneity without imposing restrictive assumptions 
on the distribution of the individual effects. Secondly, latent classes provide information on the 
structure of the underlying unobserved heterogeneity by identifying two (or more) groups of 
individuals, which typically differ in their propensities to use health care (e.g. ‘infrequent 
users’ versus ‘frequent users’ as in Bago d’Uva, 2006). However, most previous latent class 
models used to investigate the determinants of health care use, often assume that individual-
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level unobserved heterogeneity is time-invariant (with the exception of Hyppolite and Trivedi, 
2012). Importantly, this implies that individuals are not allowed to move between classes over 
time. In this paper, we relax this assumption and employ a LM model that accounts for time-
varying unobserved heterogeneity, movements between classes and the endogeneity of UD. 
More specifically, LM models can be seen an extension of latent class models for longitudinal 
data and their fundamental difference lies in the way the latent process is defined. Typical latent 
class models assume that the observed sample is drawn from a population partitioned into k 
latent classes identified by a discrete latent variable U with k support points (Lazarsfeld and 
Henry 1968; Goodman 1974). LM models additionally assume that the latent process U follows 
a first-order Markov chain with finite state space. We exploit this feature in our application.  
Despite been used in a variety of behavioural and social sciences, models including a dynamic 
latent process to account for time-varying unobserved heterogeneity are not normally employed 
to study health care use, especially in the economics literature. Yet, previous studies have 
estimated such models to explore other health-related issues. For instance, Bartolucci et al. 
(2014) propose a flexible approach which accounts for time-varying unobservables using a 
mixture of latent auto-regressive AR(1) processes. They apply this specification to study self-
reported health on data from the US Health and Retirement Study (HRS) and capture potential 
shocks changing an individual’s health or its subjective perception over time. While their 
model is highly relevant, our empirical approach differs in that is a bivariate extension of the 
LM models with a discrete latent process presented in Bartolucci and Farcomeni (2009) and it 
explores the effects of UD on health care consumption using panel administrative data. 
Furthermore, Bartolucci and Farcomeni (2015) estimate an event-history variant of the LM 
approach on data from a medical study about primary biliary cirrhosis. Interestingly, this model 
allows for both time-fixed and time-varying unobserved heterogeneity while accounting for 
informative dropout, that is when individuals are lost to follow-up due to events (e.g. death) 
linked to the main outcome of interest. Finally, and similarly to Bartolucci et al. (2009), 
Montanari and Pandolfi (2018) analyse data drawn from a longitudinal survey on the health 
status of elderly patients in nursing homes within the region of Umbria (Italy). They use an 
extended LM model which deals with different intermitting patterns of missing data and 
dropout due to death and discharge of patients.  
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3. Empirical approach 
Compared to previous studies on health care use, our LM approach presents two main 
innovations. First, we employ a bivariate specification to account for the endogeneity of UD 
via the inclusion of unobserved heterogeneity modelled as discrete latent classes. Traditionally, 
the majority of latent class models used to analyse health care consumption in the economics 
literature relied on univariate (single equation) specifications with time-invariant 
unobservables (e.g. Bago d’Uva, 2005, 2006; Deb and Trivedi, 1997). Secondly, we allow 
unobserved heterogeneity to be time-varying and thus enable individuals to move among latent 
classes over time. This accounts for changes in behaviour concerning both the propensities to 
use health care and poor glycaemic control between time periods. In doing so, we rely and 
build on the well-established LM model proposed by Bartolucci and Farcomeni (2009).  
 
In the presence of longitudinal data, the relationship between uncontrolled diabetes, 𝑈𝐷#$, and 
health care utilisation 𝐻𝐶#$, is often modelled by a standard panel data specification such that:  
 
𝐻𝐶#$∗ = 	𝛼# + 𝜷𝒙#$ + 𝛾𝑈𝐷#$ + 𝜂#$                                                                                            (1) 
 
where 𝐻𝐶#$∗  is the underlying latent counterpart of a discrete observed categorical indicator of 
health care utilisation, 𝐻𝐶#$, with 𝑗 = 0,… , 𝐽 categories where 𝐻𝐶#$ = 𝑗 is the number of GP 
or specialist visits attended by an individual i at time t with 𝑡 = 1,… , 𝑇#; 𝑈𝐷#$ is a binary 
variable taking value 1 in the presence of uncontrolled diabetes; 𝛼# is the time-invariant 
individual level unobserved heterogeneity; 𝒙#$ is a vector of observed individual 
characteristics; and 𝜂#$ captures the idiosyncratic error/shock, and could also include residual 
time-varying individual unobserved heterogeneity (𝐻#$). If we assume, for instance, that 𝜂#$ 
follows a logistic distribution, equation (1) could be estimated using either standard random or 
fixed effects ordered logit models.   
 
In this case, the effect of UD on health care use, 𝛾, could be identified by such as model if 𝑈𝐷#$ 
is uncorrelated with the time-varying individual level unobservable component, 𝐻#$, or simply 
by assuming that 𝐻#$	is negligible. While the latter assumption is often conveniently invoked 
in order to employ standard panel data techniques, in most cases this may be 
unrealistic/untenable. Hence, it might be reasonable to assume that the unobserved time-
varying factors affecting health care utilisation may also simultaneously affect UD. For 
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instance, the propensity to consume health care and the one leading to poor glycaemic control 
might be driven by a third set of common (unobserved) factors, including underlying 
(unobservable) health risks such as changes in the probability of developing specific health 
conditions as an individual ages. Hence, it might be reasonable to assume that the unobserved 
time-varying factors affecting health care utilisation may also simultaneously affect UD.  
 
Importantly, if time-varying unobserved heterogeneity is not properly accounted for, the 
estimation of 𝛾	might be biased.  In order to disentangle the genuine effect of UD on health 
care consumption and the role of time-varying unobserved heterogeneity, we jointly model the 
propensities to poor glycaemic control and health care use by employing a bivariate LM model 
(e.g. Bartolucci and Farcomeni, 2009). This allows treating time-varying unobserved 
heterogeneity,	𝐻#$, non-parametrically by including a vector of individual-specific parameters 
which follows a first-order Markov process. The potential endogeneity of UD is accounted for 
by jointly modelling 𝑈𝐷#$ and 𝐻𝐶#$. 
 
Bivariate Latent Markov Model   
We propose a bivariate LM specification to jointly model the propensities to poor glycaemic 
control and health care use. Let 𝒀#$ denote a vector collecting values of uncontrolled diabetes 
and health care utilisation, 𝑈𝐷#$ and 𝐻𝐶#$, and	𝒀9# the corresponding overall vector for the entire 
period 𝑇#. To model the distribution of 	𝒀9# given observable characteristics 𝒙#:, … , 𝒙#;, the LM 
model assumes that: i) the individual-specific random parameter 𝜶# defining unobserved 
heterogeneity follows a first-order Markov process with latent states 𝑼(𝑢)	with 𝑢 = 1,… , 𝑘; 
and ii) such latent states make 𝑈𝐷#$	and 𝐻𝐶#$ conditionally independent given the set of 
observable characteristics, 𝒙#$. The latter is a form of local independence assumption implying 
that, given the set of observable covariates in equation (1), any source of residual association 
between 𝑈𝐷#$ and 𝐻𝐶#$ is accounted for by the latent states parameters. In this setting, the 
unobserved states should capture the overall propensity to poor glycaemic control and health 
care use. Different propensities reflect unobserved time-varying factors, such as unmeasured 
health risks or attitudes towards risk, which are not captured by 𝒙#:, … , 𝒙#;.  
Our LM model is built around three sets of parameters. The first set of parameters describes 
how the joint distribution of 𝑈𝐷#$ and 𝐻𝐶#$ depends on the observable characteristics 𝒙	and the 
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latent process 𝜶#:, … , 𝜶#;. 2 From equation (1) the conditional distribution of 𝑈𝐷#$ and 𝐻𝐶#$ 
can be directly parameterised by marginal logits and log-odds ratios. In particular the first set 
of parameters can be described as follows: 
log GH𝑈𝐷#$ = 1I𝜶#$, 𝒙#$,J
GH𝑈𝐷#$ = 0I𝜶#$, 𝒙#$J
= 𝜶KL,#$ + 𝜷𝑼𝑫𝒙#$
log GH𝐻𝐶#$ ≥ 𝑗I𝜶#$, 𝒙#$, 𝑈𝐷#$	J
GH𝐻𝐶#$ < 𝑗I𝜶#$, 𝒙#$,𝑈𝐷#$J
= 𝜶PQ,RS:,#$ + 𝜷𝑯𝑪𝒙#$ + 𝛾𝑈𝐷#$
                                             (2) 
 
where 𝐻𝐶#$ = 𝑗 ↔ 𝛿RX: < 𝐻𝐶#$∗ ≤ 𝛿R	,	and 𝜶PQ,RS:,#$ = 𝜶PQ,:,#$ + 𝛿RS:. Therefore if 𝐻𝐶 has 
for example three levels (𝐽 = 2), there are 𝑘	random intercepts 𝜶PQ	and 𝐽 − 1 = 1 cut-off point 
𝛿. That is, we are assuming that random intercepts and cut-off points are linearly additive. 
Notice that 𝜶KL and 𝜶PQ	capture the relative contributions of time-varying unobserved 
heterogeneity in determining 𝑈𝐷#$ and 𝐻𝐶#$, respectively and 𝛾 is the remaining direct effect 
of uncontrolled diabetes on health care consumption (Di Mari and Bakk, 2018). Finally, to 
capture potential time-specific association between 𝑈𝐷#$ and 𝐻𝐶#$ (e.g. time-specific shocks 




c = 𝜌,																				∀𝑗 = 1,… , 𝐽          (3) 
 
where 𝜶#$ collects the vector of intercepts in the system of equations (2). Notice that all log-
odds ratios are set to be equal across different level j of health care utilisation. This implies that 
in our specification, the association between UD and HC is fixed across different levels of 
health care utilisation. While this may appear to impose a restriction, it allows us to account 
for any residual time-specific association after having conditioned on the latent process and 
substantially ease the computational burden of the model.  
 
The two remaining sets of parameters model the underlying distribution of the random 
parameter vector 𝜶𝒊𝒕. More specifically, the second set of parameters includes the initial 
probabilities Pr(𝜶𝒊𝟏) = PrH𝜶𝒊𝟏 = 𝑼(𝑢)J = 𝜋𝑢1 with u = 1, . . . , k, which are produced by a 
multinomial logit specification. These can be interpreted as the standard class membership 
probabilities in the first time period. The third set of parameters comprises the transition 
 
2 To ease the notation, we have suppressed the suffix i in 𝑇#. However, we should keep in mind that in this case 
time is individual-specific as we are employing an unbalanced panel.  
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probabilities between different latent states. Since this is a first-order Markov process, these 
depend on the previous time period such as  𝜋l]|m]no = Pr	(𝜶𝒊𝒕 = 𝑼(𝑣)|𝜶#$X: = 𝑼(𝑢)), with t 
= 2, . . . , T, and u,v = 1, . . . , k. That is, differently from most previous latent class models, 
unobserved heterogeneity is modelled as a Markov process and this allows individuals 
switching between latent classes over time. The joint distribution of the latent process 𝑼# may 
be written as: 
 
Pr(𝜶𝒊) = Pr	(𝜶𝒊𝟏 = 𝑼(𝑢))∏ Pr	(𝜶𝒊𝒕 = 𝑼(𝑣)|𝜶#$X: = 𝑼(𝑢))
;\
$r: = 𝜋m: ∏ 𝜋l]|m]no
;\
$r: 	       (4) 
 
Equation (4) shows that individuals are allowed switching between classes. These probabilities 
may be computed using a forward recursion employed in the literature concerned with a 
specific type of Markov models termed hidden Markov models (see e.g., MacDonald and 
Zucchini, 1997; Bartolucci, 2006; Farcomeni, 2012). We estimate the system (2)-(4) by 
employing a logit model for 𝑈𝐷#$ and an ordered logit model for 𝐻𝐶#$. More specifically, the 
dependent variable for 𝑈𝐷#$ is a binary variable defining the presence of UD among individuals 
with diabetes while the dependent variables for 𝐻𝐶#$ include the following ordered categories: 
0,1,2,..>55 for GP visits and 0,1,2…> 33 for specialist visits, respectively. Here, we follow 
Cameron and Trivedi (1998) who suggest that ordered discrete models could be employed as 
an alternative to count data models. In addition, this specification can be also seen as a 
nonparametric alternative to count data models (e.g. Di Mari and Bakk, 2018; Vermunt and 
Magidson, 2005). In any case, the inclusion of a count data model such as Poisson or Negative 
Binomial would require extending this bivariate Latent Markov approach well beyond the 
scope of this paper.  
 
The estimation is implemented by an EM algorithm (Dempster et al., 1977) and the 
corresponding log-likelihood of our model can be written as: 
 
ℓ(𝜽) = ∑ ∑ v∑ 𝑤#$m log[𝑝(𝒚#$|𝜶#$, 𝒙#$)]
;\
$ + 𝑤#:m log[𝜋m:] + ∑ 𝑧#m}log	(} 𝜋m~)m#                (5) 
 
where 𝜽 is the is short-hand notation for all the nonredundant model parameters 𝜶,𝜷, 𝛾	 and 𝜌,	  
𝑤#$m is a dummy variable which equals 1 if individual i is in latent state u at time t, while 	𝑧#m} 
equals the number of times individual i moves from state u to state 𝜈 (from t >1). To estimate 
𝜽, we maximize ℓ(𝜽) by using the EM algorithm proposed by Bartolucci and Farcomeni 
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(2009), that is a Newton–Raphson type iterative algorithm.3 In particular, the EM algorithm 
alternates Expectation and Maximization steps until convergence. The E-step computes 
expected values of variables 𝑤#$m and 	𝑧#m} using posterior probabilities. The subsequent M-
step maximises the expected values with respect to 𝜽.4  
4. Data 
We employ individual-level longitudinal data drawn from administrative records of patients 
followed over six consecutive years (2005-2010) in six primary care centres and two hospitals 
in the municipality of Badalona (north-east of Barcelona), Spain, serving a population of 
around 104,000 individuals. As in Spain health care is primarily delivered by a national health 
care service with free universal access, data from these health care centres should be 
representative of the way the health system operates in the whole country.  
Our data includes a rich set of information about patients’ use of health care resources, 
including number of GP visits and specialist care. We focus on utilisation as it represents the 
largest component of diabetes-related medical costs. For example, Mata-Cases et al. (2016) 
find that in Catalonia hospital care, medications and primary care are the main drivers of costs 
for both patients with type-2 diabetes and non-diabetic patients. The data also encompasses 
information on a battery of diagnostic tests, measurements of height and weight (used to build 
an individual’s body mass index, BMI); patient’s chronic and diagnosed health conditions 
(classified according to the International Classification of Primary Care codes, second edition, 
ICPC-2); type of healthcare professional(s) contacted; and the main reason for their visit. 
Moreover, the dataset includes standard individual level socio-demographic characteristics 
such as age, gender, marital status, immigration (Spanish or EU national versus non-EU 
national) and employment status (active vs retired), place of birth and residence and health-
behaviours (alcohol and tobacco use). 
Given the main objective of our study, we focus on a sub-sample of individuals diagnosed with 
type-2 diabetes mellitus (DM), aged 16 years or over, who had at least one contact with the 
aforementioned health care centres during the study period. Diabetic patients were identified 
via the corresponding ICPC-2 code or alternatively through a mean value of the glycated 
 
3 We thank Bartolucci and Farcomeni for kindly providing the initial MATLAB	codes, which we have amended to 
estimate our bivariate model. All adapted MATLAB	functions are available upon request. 
4 We have also estimated an alternative specification where UD is used as a predictor of (initial) class membership 
probabilities. Results are very similar to the ones presented here and available upon request.  
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haemoglobin (HbA1c) test ≥ 6.5% (≥ 48 mmol/mol). This test is routinely used by physicians 
to diagnose and monitor diabetes and provides an accurate measure of glucose concentration 
up until the previous 8 weeks (Goldstein et al. 2004; IEC, 2009; Lyons and Basu, 2012).  
We define uncontrolled type-2 diabetes (UD) using a binary variable which equals 1 if the 
within year mean HbA1c level is equal or above 7.5%. This is the threshold actually employed 
by physicians to identify poor glycaemic control in our dataset. However, since there is no 
universal consensus within the medical literature about the HbA1c thresholds which identify 
UD, we also estimate our models using a slightly lower value of blood sugar concentration 
(7%).5 Given the need to employ annual measurements of UD in the LM model, we restricted 
our sample to individuals with at least one within-year mean HbA1c value. Following this 
criteria, we obtained a sample of 2,455 patients with type-2 DM.6  
In our models, dependent variables for health care utilisation, GP and specialist visits, are 
ordered variables with categories 0,1,2,..>55 and 0,1,2…> 33, respectively. Covariates include 
age; gender; immigration, employment and marital status; BMI; alcohol and tobacco use; and 
a series of diagnosed conditions: asthma, chronic obstructive pulmonary disease (COPD), 
dementia, psychosis, depression and cancer. In addition, all specifications include local (health) 
areas fixed effects and wave dummies.         
Descriptive statistics  
Table 1 reports variable definitions and some basic descriptive statistics for both the sample of 
patients with type-2 DM and the one including individuals with uncontrolled diabetes 
(HbA1c>=7.5%). Our pooled dataset (years 2005-2010) reveals that around 27 percent of 
patients are not controlling adequately their blood sugar levels, despite the well-known 
potential detrimental effects. In the sample of patients with diagnosed diabetes, the mean 
number of GP visits per year is around 17.2 while this falls to 4.9 per year for specialist visits. 
 
5 Results obtained using a lower threshold appeared to be very similar and are available upon request. 
6 Note that, given the differences between type-1 and type-2 diabetes and related treatments, we dropped all 
individuals with type-1 diabetes. Individuals transferred or moved to other health centres and patients from other 
areas were also excluded from our analysis. Since movements across centres are rare events, this exclusion is 
unlikely to have a major impact on our main results. We are aware that focusing only on individuals with annual 
values of UD may imply, at least in principle, that we might be employing those individuals with more regular or 
frequent measurement of blood sugar, that is individuals who could be more conscientious or risk averse (and 
potentially healthier). If that would be the case, then the estimates obtained by our models will likely be 
downwardly biased and represent the lower bound of the effects of UD on health care utilisation. However, this 
is unlikely to generate a systematic bias in our case as virtually all individuals with type-2 diabetes present at least 






As expected, these increase among individuals with UD to 18.8 and 5.3, respectively. Patients 
with UD appear to be more active in the labour market (23 vs 19 percent); to engage more 
frequently in risky-health behaviours (smoking, 21.3 vs 17.1 percent; drinking: 3.4 vs 2.6 
percent); and suffer from higher levels of depression (21.5 vs 17.6) than diabetic patients with 
an adequate control. 
(Table 1 around here) 
 
5. Results  
We estimated our Latent Markov specification for an increasing numbers of latent states for 
each of the two measures of health care utilisation: GP and specialist visits. We do this by first 
estimating a model with the no heterogeneity (i.e. k=1) followed by models estimated with an 
increasing number of latent states. This allows establishing the specific number of latent classes 
for each outcome in our final specifications. Results are reported in Table 2. 
 
(Table 2 around here) 
 
This table shows the log-likelihoods obtained from equation (4) together with the total number 
of parameters and the Bayesian Information Criterion (BIC; Schwarz, 1978) for all models 
estimated by imposing an increasing number of latent states. Given the nature of our response 
variables and the objective of our analysis, it would be more appropriate to rely on the BIC 
rather than the Akaike Information Criterion (AIC; Akaike, 1973), as the BIC tends to penalise 
model complexity more heavily.7 According to these criteria, the specifications with the lowest 
BIC are the ones with four classes for GP visits and five classes for specialist. Below we report 
estimates for the three set of parameters produced by our LM model. These include estimates 
and partial effects of UD on GP and specialist visits; time-varying latent propensities to poor 
glycaemic control (UD) and health care use; and initial as well as transition probabilities 





7 See, among others, McLachlan and Peel (2000) for a detailed analysis of the use of information criteria to select 




Tables 3 and 4 report estimated coefficients and average partial effects (APE) obtained using 
a bivariate Latent Markov model. The left hand-side of each table reports estimates for the logit 
model for UD while the right-hand side includes results for the jointly estimated ordered logit 
model for GP and specialist visits, respectively.  
(Tables 3 and 4 around here) 
Conditional on time-varying unobservables, the direct effect of UD on the number of both GP 
and specialist visits is positive but only weakly statistically significant (at 10% significance 
level, see Table 3) or not statistically significant (Table 4). This appears to suggest that low 
levels of glycaemic control do not increase health care use within our population of individuals 
with type-2 diabetes. Moreover, the absence of any residual association between UD and health 
care consumption (for both GP and specialist visits) implies that, after controlling for (time-
varying) unobservables, the association between UD and health care use tend to disappear. This 
lends some further support to the idea that UD and health care utilisation might be jointly driven 
by a third set of common time-varying unobserved factors and that UD may not be a genuine 
determinant of health care use.8   
Yet, a number of observed variables appear to be important drivers of utilisation. For example, 
in Table 3 (UD and GP visits), gender and age display positive and highly statistically 
significant coefficients with APE of around 0.056 and 0.004. This implies that women and 
older individuals present an increased probability of an additional GP visit of 5.6 and 0.4 
percentage points (pp), respectively. As expected, a battery of health conditions including 
asthma, COPD, dementia, depression, and the occurrence of cancer also increase the average 
annual probability of an additional GP visit with the largest quantitative effects estimated for 
COPD and depression (14.3 and 9.3pp). Similarly, being employed decreases by 7.9pp the 
probability of a further annual GP visit as well as a higher BMI, although only by 0.6pp. 
Interestingly, only a handful of conditions such as COPD (7.7pp), depression (3.8pp) and 
cancer (4.8pp) seem to significantly increase the probability of a further annual visit to a 
specialist (Table 4). Also, being employed (-2.9pp), tobacco consumption (-2.0pp) and living 
within health areas 4 (-3.1pp) and 7 (-7.2pp) seem to decrease the same probability. Note that 
 
8 Following Gil et al. (2017) we also estimated our models by interacting UD with the gender variable in order to 
capture potential systematic gender-related differences. Results do not differ substantially and the estimated 
interaction terms for both models (GP and specialist visits) are not statistically significant. Estimates are available 
upon request.  
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given the complexity of the decision-making process leading to a specialist visit, which 
includes both a patient and the GP or the health care provider more generally, it is not surprising 
that the probability of an additional visit would mainly depend on the occurrence of major 
health conditions. Furthermore, the effects of the different administrative health areas on health 
care utilisation might reflect broader differences in socioeconomic status between individuals 
living in such areas as well as the other geographical factors, including proximity to hospitals 
and primary care centres.     
Being a non-EU immigrant (19.2pp); living within a family or a partner (3.7pp); being a smoker 
(4.3pp); a higher BMI (2.9pp); and a series of diagnosed conditions such as dementia (16.8pp); 
depression (5.2pp); as well as living within specific health administrative areas (areas 4-7 with 
APE of 4.1, 6.6, 10.4 and 8.2pp, respectively) all appear to significantly increase the probability 
of poor glycaemic control in our LM model including UD and GP visits. Conversely, women 
(-2.0pp); being affected by psychosis (-8.6pp); and older age (-0.2pp) decrease the probability 
of poor control. As for our specification including UD and specialist visits, only variables 
related to specific health behaviours, such as smoking (4.3pp) and BMI (2.6pp), living within 
health areas 6 (6.4pp) and 7 (4.8pp), and more importantly dementia (23.2pp), increase the 
probability of UD. In addition, older individuals (-0.3pp) and living in health area 2 (-5.1pp) 
are less prone to poor glycaemic control.    
Time-varying unobserved heterogeneity  
Tables 5 and 6 report estimated intercepts 𝜶KL and 𝜶PQ		described in equation (2) for each of 
the estimated latent states for models with primary care (GP visits) and secondary care 
(specialist visits). We exploit these parameters to recover the conditional average probabilities 
for each model (last two columns of the tables). These could be interpreted as the propensities 
to poor glycaemic control (UD) and a more frequent use of health care between latent states. 
That is, a utilisation higher than the median quantity of health care for each latent state with 
the median values corresponding to 15 and 3 visits for GP and specialist visits, respectively. 
 (Tables 5 and 6 around here) 
Table 5 reveals that there are four unobserved types of individuals with type-2 diabetes with 
varying propensities to UD and health care use (GP visits). More specifically, types 1 and 4 
display similar high propensities towards health care consumption (around 57 and 59 percent, 
respectively). However, these two types differ markedly in their propensities to poor glycaemic 
control, i.e. type 4 presents a much higher propensity to UD (around 87 percent) if compared 
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to type 1 (about 6.5 percent) as well as types 2 and 3. Moreover, whereas types 2 and 3 share 
similar propensities to UD (around 32 and 23 percent), type 2 individuals appear much more 
likely to use health care than type 3 (95 versus 12.2 percent). This implies that not all 
individuals with a high propensity to GP visits present an equally high propensity to poor 
glycaemic control. Combinations of high propensities to health care consumption and adequate 
glycaemic control could point towards the presence of conscientious patients who tend to use 
more health care to better control their condition. Equally, types with combinations of high 
propensities to UD and GP visits (type 4) might include potentially less conscientious 
individuals who are not adequately following their prescribed health care treatments, ultimately 
resulting in extra utilisation.  
The model estimated for secondary care presents five latent states (Table 6). Individuals in 
latent state 1 show relatively low propensities to both UD and specialist visits (around 11.5 and 
19.2 percent) while individuals in latent states 3 and 4 present low propensities to UD (10 and 
9.3 percent) but much larger ones to health care use (about 80 and 98 percent), thus also 
potentially revealing the presence of more conscientious individuals. Yet, type 5 includes 
individuals with large propensities to UD and secondary care. This might confirm the existence 
of patients not effectively controlling their blood sugar levels and more prone to consume 
secondary care. Still, it should be kept in mind that the propensities to additional GP and 
specialist visits should not be directly compared, as within the Spanish health care system 
access to secondary care would require a GP referral.      
Changes between latent states over time 
Our bivariate LM model enables us to investigate whether individuals move between latent 
states, therefore changing their propensities to UD and health care use over time. Tables 7 and 
8 report estimated initial and transition probabilities between latent states across consecutive 
time periods. As for the initial probabilities, in both tables the largest proportion of individuals 
is expected to be in state 1. This is also the latent state from where patients are more likely to 
move out over time, as pointed out by the subsequent transition probabilities.    
(Tables 7 and 8 around here) 
Looking at transition probabilities (right-hand side of each table), the rows of each matrix 
contain previous (t -1) latent states whereas the columns represent current latent states. Both 
matrices show a symmetric structure, especially the one computed for the model with UD and 
GP visits (Table 7) i.e., individuals present high probabilities of remaining in the same latent 
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state in the following period with the largest “persistence” identified for individuals in state 2. 
However, both tables suggest the presence of transitions between latent states across time. For 
example, in Table 7 individuals in latent state 1 at t -1 present probabilities of moving towards 
latent states 2, 3 and 4 in the subsequent period of around 2, 4.3 and 5.9 percent, respectively. 
This implies that individuals with a high propensity to GP visits and a low propensity to poor 
glycaemic control (latent state 1) in one period could change their behaviour over time and 
present substantially higher propensities to UD and GP visits (latent states 2 and 4) as well as 
higher propensities to UD and a lower propensity to GP visits (latent state 3) in subsequent 
periods. Similarly, individuals in latent state 4 could migrate to latent states 1 (3.8), 2 (2.9) and 
3 (0.7) and present a much lower propensity to poor glycaemic control while still having a high 
propensity to consume health care (especially in latent state 2).  
Estimated transitions probabilities in Table 8 also suggest that there might be changes in the 
propensities to UD and specialist visits between consecutive periods. These movements appear 
to be concentrated among patients initially in latent state 1 (low propensities to UD and health 
care use) who could move to type 3 (16 percent; still low UD but very high health care use) 
and to a lesser extent to types 2 (7 percent; very high UD and higher health care use) and 4 (0.2 
percent; low UD and also very high health care use) in subsequent periods. Type 2 individuals 
(very high UD and low health care use) might also fluctuate, especially towards state 5 (15.7 
percent; very high UD and health care use) while type 3 (low UD and high health care use) 
have increased probabilities to switch to type 4 (8 percent; low UD and very high health care 
use). Overall, the estimated transitions appear to suggest further increases in the propensities 
to UD or specialist visits, mostly among patients with already higher propensities for these.  
Moreover, we tested the hypothesis of diagonal transition matrices in our models, i.e. that there 
are no transitions between latent states (or that unobserved heterogeneity for UD and health 
care use is time-invariant). We followed a test specifically designed for LM models proposed 
by Bartolucci (2006), who showed that the asymptotic null distribution of the likelihood ratio 
(LR) statistic is of  χ type. In our case, the LR statistics for models with GP and specialist 
visits are equal to 141.05 and 280.03 with 12 and 20 degree of freedom, respectively. This led 
us to strongly reject the null hypothesis of diagonal transition matrices. This also appears to 
suggest that unobserved heterogeneity might not be time-invariant. 
The dynamics of the time-varying unobserved heterogeneity can be explored further by 
computing the year-specific probabilities of each latent state (Figures 1 and 2).  
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(Figures 1 and 2 about here) 
As for our specification including primary care (Figure 1), while probability of being in latent 
state 1 is the highest in all periods, it also appears to decline over time. Conversely, the 
probabilities of being in latent states 2, 3 and 4 appear to slightly increase over time. Overall, 
this appears to suggest that individuals tend to become more inclined to poor glycaemic control 
and health care use over time (apart from individuals in latent state 3 who present a higher 
propensity to UD, but a comparatively lower propensity to additional GP visits). The same 
probabilities computed for the model with UD and secondary care (Figure 2) display a 
substantial and constant decrease in the probability of being in latent state 1 as well as similar 
consistent increase in the probability of being in latent state 3 (low UD and very high health 
care use) over time. Furthermore, the probabilities of being in the remaining latent states also 
appear to increase between 2006 and 2010, especially the one for latent class 4 (very high 
propensities to UD and health care use). 
6. Conclusions and discussion 
This paper proposes a bivariate Latent Markov (LM) model to explore the relationship between 
uncontrolled diabetes (UD) and health care utilisation on a sample of patients with type-2 
diabetes drawn from longitudinal administrative data collected in Spain. Our approach offers a 
series of substantial and innovative modelling features, which enable accounting 
simultaneously for time-varying unobserved heterogeneity; changes in individuals’ behaviours 
over time via switches between latent classes; and the endogeneity of uncontrolled diabetes. 
Until now, these potentially important issues have been largely ignored, especially by the 
previous medical literature concerned with UD. Furthermore, whilst UD is a widespread 
condition with potentially severe health consequences, there is still sparse evidence on its 
effects on health care utilisation outside the US and within the economic literature. Finally, 
previous latent class models used to investigate the determinants of health care utilisation do 
not generally account for dynamic unobserved heterogeneity.  
We estimate our LM model to quantify the effects of UD on the consumption of both primary 
and secondary health care. Contrary to previous evidence based on univariate models, we find 
that UD does not appear to have a significant direct effect on GP or specialist visits, given the 
dynamic latent process. Moreover, the association between UD and health care use tend to 
disappear when controlling for unobservable factors, suggesting that these may drive part of 
their otherwise perceived association. Our specifications also suggest that such unobserved 
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factors are time-varying by rejecting time-invariant unobservables and identifying the presence 
of individuals switching between latent classes over time. These movements between classes 
show a tendency towards higher propensities to poor glycaemic control and health care use, 
potentially reflecting changes in behaviours. Our models also reveal differences in the 
propensities to poor glycaemic control and health care utilisation between latent states. This 
suggests the presence of heterogeneity in behaviours involving UD and health care use within 
our sample of patients, which may go beyond the standard groupings of “frequent” versus 
“infrequent” users. Ultimately, by ignoring time-varying unobserved heterogeneity and the 
endogeneity of uncontrolled diabetes, the effects of UD on health care utilisation might be 
overestimated and this could lead to biased findings and misleading policy implications. 
Overall, our findings appear to challenge the conventional wisdom within the current literature 
advocating that UD is one of main drivers of health care utilisation and related costs among 
patients with diabetes. This may have important implications for physicians, policy makers and 
more generally the development of diabetes management plans, potentially suggesting the need 




Tables and figures 






Variable Description Mean SD Mean SD 
UD Uncontrolled Type-2 diabetes (*) 0.267 0.44 - - 
Mean HbA1c Within year mean HbA1c value 6.983 0.95 8.47 1.00 
GP visits Number of GP visits 17.194 9.74 18.804 10.65 
Spec. visits Number of specialist visits 4.968 5.33 5.327 5.62 
Gender 1= female, 0 otherwise 0.528 0.50 0.511 0.50 
Age Age in years 66.534 9.78 66.423 10.34 
Immigrant 1 = Non-EU immigrant, 0 otherwise 0.007 0.08 0.013 0.11 
Employment  1 = Labour market active, 0 otherwise 0.191 0.39 0.229 0.42 
Marital status  1 = Not living alone, 0 otherwise 0.880 0.32 0.887 0.32 
Alcohol 1 = Drink alcohol, 0 otherwise 0.026 0.16 0.034 0.18 
Tobacco 1 = Smoker, 0 otherwise 0.171 0.38 0.213 0.41 
BMI Body Mass Index (BMI) 30.169 4.82 30.52 5.11 
Asthma  1 = Ashma, = otherwise 0.047 0.21 0.046 0.21 
COPD 1 = COPD, 0 otherwise 0.054 0.23 0.054 0.22 
Dementia 1 = Dementia, 0 otherwise 0.010 0.10 0.015 0.12 
Psychosis  1 = Phycosis, 0 otherwise 0.010 0.10 0.011 0.11 
Depression 1 = Depression, 0 otherwise 0.176 0.38 0.215 0.41 
Cancer 1 = Malignant neoplasm, 0 otherwise 0.066 0.25 0.065 0.25 
Area 1 1 = Health area 1 0.083 0.28 0.073 0.26 
Area 2 1 = Health area 3 0.137 0.34 0.097 0.30 
Area 3 1 = Health area 8  0.164 0.37 0.158 0.37 
Area 4 1 = Health area 9 0.205 0.40 0.215 0.41 
Area 5 1 = Health area 10 0.121 0.33 0.120 0.32 
Area 6 1 = Health area 12 0.159 0.37 0.180 0.38 
Area 7 1 = Health area 15 0.132 0.34 0.157 0.36 
           










Table 2: Model selection criteria        
 GP   Specialist   
k LL #par BIC LL #par BIC 
1 -39110.64 108 79064.31 -31957.58 86 64586.46 
2 -37885.96 113 76653.98 -30884.95 91 62480.23 
3 -37427.42 120 75791.56 -30269.26 98 61303.49 
4 -37015.81 129 75038.58 -29959.95 107 60755.13    
5 -37639.51 140 76371.84 -29747.98 118 60417.05    
6    -29718.20 131 60458.96    
Notes: k= latent classes; LL = log-likelihood; #par=number of estimated parameters; BIC=Bayesian Information 




















Table 3: Bivariate latent Markov model - UD and GP visits      
 UD       GP       
 Coeff. SE Z APE Coeff. SE Z APE 
UD     0.4791 0.28 1.69 0.0491 
Gender -0.2047 0.10 -2.13 -0.0207 0.5471 0.07 7.31 0.0562 
Age -0.0202 0.01 -3.45 -0.0020 0.0439 0.00 9.70 0.0045 
Nationality  1.5442 0.39 3.96 0.1920 -0.2048 0.30 -0.67 -0.0211 
Employment  0.1539 0.15 1.06 0.0157 -0.7657 0.11 -6.84 -0.0787 
Marital status  0.3898 0.15 2.67 0.0375 0.0181 0.10 0.17 0.0019 
Alcohol 0.2046 0.24 0.87 0.0213 0.1384 0.17 0.80 0.0143 
Tobacco 0.4079 0.12 3.53 0.0429 -0.1100 0.10 -1.15 -0.0113 
BMI 0.2838 0.04 7.53 0.0287 -0.0582 0.02 -2.36 -0.0060 
Asthma  -0.0959 0.21 -0.46 -0.0095 0.6242 0.18 3.54 0.0637 
COPD -0.0248 0.19 -0.13 -0.0025 1.4532 0.13 11.55 0.1438 
Dementia 1.3766 0.32 4.27 0.1678 0.6296 0.30 2.12 0.0642 
Psychosis  -0.9846 0.48 -2.07 -0.0858 0.0636 0.31 0.20 0.0066 
Depression 0.4875 0.11 4.51 0.0517 0.9270 0.08 11.39 0.0938 
Cancer  0.0822 0.15 0.55 0.0084 0.3164 0.11 2.76 0.0325 
Area 2 -0.0385 0.22 -0.17 -0.0039 -0.1442 0.15 -0.93 -0.0149 
Area 3 0.1632 0.20 0.80 0.0168 -0.0659 0.14 -0.47 -0.0068 
Area 4 0.3962 0.19 2.04 0.0415 0.3170 0.14 2.29 0.0326 
Area 5 0.6080 0.21 2.96 0.0658 0.1193 0.15 0.80 0.0123 
Area 6 0.9367 0.20 4.75 0.1041 0.1995 0.14 1.38 0.0205 
Area 7 0.7505 0.21 3.56 0.0823 0.4361 0.15 2.96 0.0447 
Wave dummies yes    yes    
         
Residual correlation                 
Corr.         -0.3186 0.2842 -1.1212   
Notes: this table displays coefficients and average partial effects (APE) obtained from a bivariate Latent Markov 
Model. UD = uncontrolled diabetes; GP = number of GP visits; SE = standard errors; Z = z-score; APE = Average 










Table 4: Bivariate latent Markov model - UD and specialist visits      
 UD       Specialist       
 Coeff. SE Z APE Coeff. SE Z APE 
UD     0.5651 0.35 1.60 0.0477 
Gender -0.1457 0.12 -1.20 -0.0128 0.0908 0.08 1.07 0.0076 
Age -0.0293 0.01 -3.71 -0.0026 0.0084 0.01 1.56 0.0007 
Nationality  1.9173 0.40 4.85 0.2293 0.5038 0.39 1.28 0.0425 
Employment  -0.0438 0.17 -0.26 -0.0038 -0.3414 0.11 -3.07 -0.0287 
Marital status  0.0874 0.18 0.48 0.0076 0.1770 0.11 1.61 0.0149 
Alcohol 0.3888 0.31 1.27 0.0362 -0.0994 0.19 -0.53 -0.0084 
Tobacco 0.4691 0.14 3.39 0.0430 -0.2376 0.10 -2.41 -0.0200 
BMI 0.2997 0.04 6.85 0.0263 -0.0253 0.03 -0.90 -0.0021 
Asthma  0.1853 0.24 0.77 0.0167 0.2358 0.14 1.64 0.0199 
COPD -0.1163 0.25 -0.47 -0.0101 0.9211 0.14 6.48 0.0774 
Dementia 1.9392 0.34 5.78 0.2319 0.3771 0.32 1.19 0.0318 
Psychosis  -0.5936 0.54 -1.10 -0.0481 -0.8028 0.34 -2.33 -0.0666 
Depression 0.2235 0.14 1.63 0.0201 0.4475 0.08 5.33 0.0377 
Cancer 0.2215 0.18 1.21 0.0201 0.5663 0.13 4.41 0.0478 
Area 2 -0.6245 0.29 -2.17 -0.0510 -0.1759 0.15 -1.15 -0.0148 
Area 3 0.0943 0.25 0.38 0.0084 -0.1526 0.16 -0.98 -0.0128 
Area 4 0.1980 0.24 0.83 0.0177 -0.3770 0.15 -2.55 -0.0316 
Area 5 0.2514 0.26 0.98 0.0228 -0.0679 0.15 -0.44 -0.0057 
Area 6 0.6779 0.25 2.74 0.0641 -0.2175 0.15 -1.44 -0.0183 
Area 7 0.5137 0.25 2.09 0.0479 -0.8700 0.16 -5.41 -0.0724 
Wave dummies yes    yes    
         
Residual correlation                 
Corr.         -0.5919 0.3567 -1.6593   
Notes: this table displays coefficients and average partial effects (APE) obtained from a bivariate latent Markov 
Model. UD = uncontrolled diabetes; Specialist = number of specialist visits; SE = standard errors; Z = z-score; 
APE = Average Partial Effects. This specification includes the full set of covariates, health area fixed effects and 












Table 5: Latent states - 
GP visits             
Latent states  Estimated intercepts  Conditional average probabilities  
 α SE α SE UD GP 
1 4.6249 1.19 6.3122 0.94 0.0656 0.5683 
2 6.6825 1.20 9.3181 0.98 0.3181 0.9475 
3 6.1784 1.21 3.6631 0.95 0.2291 0.1220 
4 9.6861 1.22 6.4020 1.03 0.8721 0.5864 
Notes: this table reports estimated α and α as described by eq. (2), and conditional average probabilities of reporting 




Table 6: Latent states – specialist visits        
Latent states  Estimated intercepts  Conditional average probabilities  
 α SE α SE UD Specialist 
1 5.7392 1.40 -0.9789 0.90 0.1152 0.1926 
2 10.4198 1.43 -0.4554 1.05 0.8888 0.2806 
3 5.5758 1.39 2.0110 0.90 0.1007 0.7956 
4 5.4764 1.39 4.6897 0.91 0.0927 0.9815 
5 9.5282 1.42 3.2509 1.05 0.7812 0.9278 
Notes: this table reports estimated α and α as described by eq. (2), and conditional average probabilities of reporting 





















Table 7: Initial and transition probabilities between latent states - UD and GP visits  
 Initial Prob. Transition Prob. 
Latent states  1 2 3 4 
1 0.6149 0.8774 0.0201 0.0435 0.0590 
2 0.1134 0.0003 0.9996 0.0000 0.0001 
3 0.1543 0.0067 0.0000 0.9800 0.0133 
4 0.1174 0.0379 0.0291 0.0073 0.9257 
  
 
 Table 8: Initial and transition probabilities between latent states – UD and specialist visits  
 Initial Prob. Transition Prob. 
Latent states  1 2 3 4 5 
1 0.5270 0.7676 0.0694 0.1611 0.0020 0.0000 
2 0.0805 0.0157 0.7921 0.0350 0.0000 0.1572 
3 0.2413 0.0076 0.0187 0.8666 0.0791 0.0280 
4 0.0804 0.0035 0.0000 0.0283 0.9268 0.0414 
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